Showing results (31-40 of 123) with videos related to

Sort By:
Pageof 13
Chemotherapy|February 9, 2013
A retrospective study of the novel combination of paclitaxel and S1 for pretreated advanced non-small cell lung cancerNana Aono, Yuri Ito, Kazumi Nishino, et al.
Plos One|November 27, 2013
Quantitative identification of mutant alleles derived from lung cancer in plasma cell-free DNA via anomaly detection using deep sequencing dataYoji Kukita, Junji Uchida, Shigeyuki Oba, et al.
JTO Clinical and Research Reports|May 2, 2022
TP53 Loss of Heterozygosity Induces De Novo SCLC Formation in EGFR-Mutated Lung Adenocarcinoma: A Case ReportKei Kunimasa, Yosuke Hirotsu, Kenji Amemiya, et al.
Molecular and Clinical Oncology|July 8, 2017
Protein and mRNA expression of folic acid-associated enzymes as biomarkers for the cytotoxicity of the thymidylate synthase-targeted drugs, pemetrexed and S-1, in non-small cell lung cancerMadoka Kimura, Fumio Imamura, Takako Inoue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomasKazuya Taniguchi, Junji Uchida, Kazumi Nishino, et al.
Scientific Reports|August 8, 2022
Fragment size and dynamics of EGFR-mutated tumor-derived DNA provide prognostic information regarding EGFR-TKI efficacy in patients with EGFR-mutated NSCLCKei Kunimasa, Kazumi Nishino, Yoshiharu Sato, et al.
Scientific Reports|May 6, 2021
The ratio of T790M to EGFR-activating mutation predicts response of osimertinib in 1st or 2nd generation EGFR-TKI-refractory NSCLCMotohiro Tamiya, Akihiro Tamiya, Norio Okamoto, et al.
Biochemical and Biophysical Research Communications|March 13, 2012
4-Hydroxy-2-nonenal induces chronic obstructive pulmonary disease-like histopathologic changes in miceTakayuki Takimoto, Mitsuhiro Yoshida, Haruhiko Hirata, et al.
Internal Medicine (Tokyo, Japan)|March 8, 2005
Pulmonary coccidioidomycosis that formed a fungus ball with 8-years durationTadashi Osaki, Hiroshi Morishita, Hajime Maeda, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 20, 2015
Analysis of ERBB ligand-induced resistance mechanism to crizotinib by primary culture of lung adenocarcinoma with EML4-ALK fusion geneMadoka Kimura, Hiroko Endo, Takako Inoue, et al.
Pageof 13